Update on cephalosporin resistance and the role of sulbactam/cefoperazone. Satellite symposiumClinical infectious diseases. 1997, Vol 24, Num 3, pp 486-505, issn 1058-4838Conference Proceedings

Pharmacodynamics Modeling To Optimize Dosage Regimens of SulbactamJARURATANASIRIKUL, Sutep; WONGPOOWARAK, Wibul; AEINLANG, Nanchanit et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3441-3444, issn 0066-4804, 4 p.Article

Rational antibiotic therapy and the position of ampicillin/sulbactamLODE, Hartmut M.International journal of antimicrobial agents. 2008, Vol 32, Num 1, pp 10-28, issn 0924-8579, 19 p.Article

Detection of bacterial strains producing sulbactam or tazobactam-sensitive β-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibioticsBANIC, S.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2006, Vol 114, Num 1, pp 3-9, issn 0903-4641, 7 p.Article

Response of enteric gram-negative bacteria to disks containing 20 micrograms each of ampicillin and sulbactamISENBERG, H. D; ALPERSTEIN, P; FRANCE, K et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 2, pp 523-524, issn 0095-1137Article

Sulbactam-containing β-lactamase inhibitor combinationsAKOVA, M.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 185-188, issn 1470-9465, 4 p.Conference Paper

Fast high performance liquid chromatography method for in-process control of sulbactamGOMIS, Domingo Blanco; SANCHEZ NUNEZ, Noé; ANDRES GARCIA, Elena et al.Analytica chimica acta. 2003, Vol 498, Num 1-2, pp 1-8, issn 0003-2670, 8 p.Article

Placental transfer of cefoperazone and sulbactam in the isolated in vitro perfused human placentaFORTUNATO, S. J; BAWDON, R. E; BAUM, M et al.American journal of obstetrics and gynecology. 1988, Vol 159, Num 4, pp 1002-1006, issn 0002-9378Article

Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumanniiCHOI, J. Y; SOO PARK, Y; CHO, C. H et al.Clinical microbiology and infection. 2004, Vol 10, Num 12, pp 1098-1101, issn 1198-743X, 4 p.Article

Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patientsKAYE, K. S; HARRIS, A. D; GOLD, H et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 4, pp 1004-1009, issn 0066-4804Article

Klinische Charakteristika und Auslöser des Baboon-Syndroms = Clinical characteristics and the causes of the baboon syndromeSCHULTZ, E. S; DIEPGEN, T. L.Dermatosen in Beruf und Umwelt. 1996, Vol 44, Num 6, pp 266-269, issn 0343-2432Article

In vitro activities of β-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteriaWANG, Fu-Der; LIN, Mei-Lin; LEE, Wen-Sen et al.International journal of antimicrobial agents. 2004, Vol 23, Num 6, pp 590-595, issn 0924-8579, 6 p.Article

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumanniiGIAMARELLOS-BOURBOULIS, Evangelos J; XIROUCHAKI, Evangelia; GIAMARELLOU, Helen et al.Diagnostic microbiology and infectious disease. 2001, Vol 40, Num 3, pp 117-120, issn 0732-8893Article

In vitro activity of cefoperazone-sulbactam : Singapore experienceKUMARASINGHE, G; CHOW, C; CHIU, C et al.Southeast Asian journal of tropical medicine and public health. 1996, Vol 27, Num 4, pp 734-737, issn 0125-1562Article

In vitro effects of sulbactam combinations with different antibiotic groups against Clinical Acinetobacter baumannii isolatesDEVECI, Aydin; COBAN, Ahmet Yilmaz; ACICBE, Ozlem et al.Journal of chemotherapy (Testo stampato). 2012, Vol 24, Num 5, pp 247-252, issn 1120-009X, 6 p.Article

Piperacillin-sulbactam versus piperacillin-tazobactam : a multicentre, randomised, single-blind, controlled clinical trialZONG ZHIYONG; LÜ XIAOJU; DUAN MINGGANG et al.International journal of antimicrobial agents. 2005, Vol 26, Num 1, pp 22-27, issn 0924-8579, 6 p.Article

Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of β-lactamaseBUYNAK, John D; GHADACHANDA, Venkat Rao; VOGETI, Lakshminaryana et al.Journal of organic chemistry. 2005, Vol 70, Num 11, pp 4510-4513, issn 0022-3263, 4 p.Article

Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgeryWILDFEUER, A; MALLWITZ, J; GOTTHARDT, H et al.Infection. 1997, Vol 25, Num 4, pp 258-262, issn 0300-8126Article

β-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazoneWILLIAMS, J. D.Clinical infectious diseases. 1997, Vol 24, Num 3, pp 494-497, issn 1058-4838Conference Paper

In vitro effect of ampicillin/sulbactam on Acinetobacter speciesHOSTACKA, A.Microbios. 2001, Vol 106, pp 97-104, issn 0026-2633, SUP2Article

Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones : Importance of residues 216 to 218 in class A β-lactamasesSABBAGH, Y; THERIAULT, E; SANSCHAGRIN, F et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 9, pp 2319-2325, issn 0066-4804Article

Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coliO'SHAUGHNESSY, E. M; FAHLE, G. A; WITEBSKY, F. G et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 7, pp 1902-1903, issn 0095-1137Article

Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam : Analysis of the correlations between in vitro test results and clinical responseJONES, R. N; DUDLEY, M. N.Diagnostic microbiology and infectious disease. 1997, Vol 28, Num 1, pp 5-18, issn 0732-8893Article

Intérêt du sulbactam dans le traitement d'une bactériémie à Serratia marcescens = Sulbactam treatment of a Serratia marcescens bacteremiaPAGE, Y; AUBERT, G; TARDY, B et al.Médecine et maladies infectieuses. 1997, Vol 27, Num JUN, pp 650-653, issn 0399-077XConference Paper

Simultaneous analysis of amoxicillin and sulbactam in human plasma by HPLC-DAD for assessment of bioequivalenceQI PEI; YANG, Guo-Ping; LI, Zuo-Jun et al.Journal of chromatography. B. 2011, Vol 879, Num 21, pp 2000-2004, issn 1570-0232, 5 p.Article